EQRXW logo

EQRx (EQRXW) Company Overview

Profile

Full Name:

EQRx, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

December 20, 2021

Indexes:

Not included

Website:

http://www.eqrx.com

Description:

EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. Its product pipeline in development includes Aumolertinib, an EGFR inhibitor for the treatment of ?EGFR-mutated? non-small cell lung cancer (NSCLC); Sugemalimab, an anti-PD-L1 antibody for the treatment of ?stage III and IV ?NSCLC; Lerociclib, a CDK4/6 inhibitor to treat HR+/HER2- breast cancer; and EQ176, an anti-PD-1?antibody for the treatment of liver cancer. The company has partnerships with Exscientia and AbCellera Biologics Inc. EQRx, Inc. was founded in 2020 and is based in Cambridge, Massachusetts.

Key Details

Price

$0.05

Market Cap

-

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-

PE Ratio

-

Annual ROE

-12.17%

Annual Debt To Equity

0.00

Beta

0.00

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with EQRXW included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.05
EQRXW price is $0.05

Price All-time High

$1.14
EQRXW price is currently -96.01% below its historical high of $1.14

Price Analysts Target

-
EQRXW price consensus analysts' forecast is unknown

Price Most Recent Change

-
EQRXW price change on Feb 6, 2025 is unknown

Price YTD Change

-
EQRXW price ytd change is unknown

Price 3-Year Change

-
EQRXW price 3-year change is unknown

Market cap

Market Cap

-
EQRXW market capitalization value is unknown

Market Cap 3-Year Change

-
EQRXW market capitalization 3-year change is unknown

Market Cap All-time High

-
EQRXW market capitalization all-time high is unknown

Market Cap Sector Rank

-
EQRXW market capitalization is unknown

Technical

Beta

0.00
EQRXW beta is 0.00

200-day SMA

$0.16
EQRXW price is currently -72.26% below its 200-day simple moving average

14-day RSI

48.15
EQRXW 14-day relative strength index is 48.15

30-day Relative Volume

4.44
EQRXW 30-day relative volume is 4.44

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$0.00
EQRXW annual revenue is $0.00

Annual Revenue Analysts Estimate

-
EQRXW annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

0%
EQRXW {parameterFullLabel} has remained unchanged year-on-year

Annual Revenue Sector Rank

-
EQRXW annual revenue is unknown

Profit

Annual Gross Profit

-
EQRXW annual gross profit value is unknown

Annual Gross Margin

-
EQRXW annual gross profit margin value is unknown

Annual Operating Profit

-$355.88 M
EQRXW annual operating income is -$355.88 million

Annual Operating Margin

-
EQRXW annual operating profit margin value is unknown

Annual Net Income

-$169.09 M
EQRXW annual net profit is -$169.09 million

Annual Net Margin

-
EQRXW annual net profit margin value is unknown

EPS

Annual EPS

-
EQRXW annual earnings per share value is unknown

Annual EPS Analysts Estimate

-
EQRXW annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

-
EQRXW annual earnings per share 1-year change is unknown

Annual EPS Sector Rank

-
EQRXW annual earnings per share is unknown

ROA & ROE

Annual ROA

-11.62%
EQRXW annual return on assets is -11.62%

Annual ROE

-12.17%
EQRXW annual return on equity is -12.17%

EBIT & EBITDA

Annual EBIT

-$355.88 M
EQRXW annual earnings before interest & taxes is -$355.88 million

Annual EBITDA

-$517.58 M
EQRXW annual EBITDA is -$517.58 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
EQRXW price to earnings ratio value is unknown

PE Ratio Sector Rank

-
EQRXW price to earnings ratio is unknown

PB Ratio

PB Ratio

-
EQRXW price to book ratio value is unknown

PB Ratio Sector Rank

-
EQRXW price to book ratio is unknown

PS Ratio

PS Ratio

-
EQRXW price to sales ratio value is unknown

PS Ratio Sector Rank

-
EQRXW price to sales ratio is unknown

Enterprise value

Enterprise Value

-
EQRXW enterprise value value is unknown

Enterprise Value Sector Rank

-
EQRXW enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
EQRXW EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
EQRXW EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

27.51
EQRXW annual current ratio is 27.51

Annual Quick Ratio

-
EQRXW annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.00
EQRXW annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-
EQRXW annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
EQRXW piotroski f-score value is unknown

Altman Z-Score

-
EQRXW altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$1.46 B
EQRXW annual total assets is $1.46 billion

Annual Non Current Assets

$26.93 M
EQRXW annual long term assets is $26.93 million

Annual Current Assets

$1.43 B
EQRXW annual total current assets is $1.43 billion

Annual Cash & Cash Equivalents

$494.14 M
EQRXW annual cash & cash equivalents is $494.14 million

Equity

Annual Book Value

$1.39 B
EQRXW annual book value is $1.39 billion

Annual Working Capital

$1.38 B
EQRXW annual working capital is $1.38 billion

Liabilities

Annual Total Liabilities

$66.15 M
EQRXW annual total liabilities is $66.15 million

Annual Total Long Term Liabilities

$14.24 M
EQRXW annual total long term liabilities is $14.24 million

Annual Current Liabilities

$51.92 M
EQRXW annual total current liabilities is $51.92 million

Annual Accounts Payable

$19.95 M
EQRXW annual accounts payable is $19.95 million

Debt

Annual Total Debt

$3.83 M
EQRXW annual total debt is $3.83 million

Annual Total Debt 1-Year Change

+13.54%
EQRXW annual total debt is up +13.54% year-on-year

Annual Long Term Debt

$1.46 M
EQRXW annual long term debt is $1.46 million

Annual Short Term Debt

-
EQRXW annual short term debt value is unknown

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$355.88 M
EQRXW annual total expenses is $355.88 million

Annual Operating Expenses

$355.88 M
EQRXW annual total operating expenses is $355.88 million

Annual Cost Of Goods Sold

-
EQRXW annual cost of goods sold value is unknown

Annual SGA

$127.38 M
EQRXW annual SGA is $127.38 million

Annual D&A

$935.00 K
EQRXW annual depreciation & amortization is $935.00 thousand

Annual Interest Expense

-
EQRXW annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$287.27 M
EQRXW annual cash flow from operations is -$287.27 million

Annual CFO 1-Year Change

-56.82%
EQRXW annual cash flow from operations is down -56.82% year-on-year

Annual CFI

-$897.28 M
EQRXW annual cash flow from investing activities is -$897.28 million

Annual CFI 1-Year Change

-20072.59%
EQRXW annual cash flow from investing activities is down -20072.59% year-on-year

Annual CFF

$139.00 K
EQRXW annual cash flow from financing activities is $139.00 thousand

Annual CFF 1-Year Change

-99.99%
EQRXW annual cash flow from financing activities is down -99.99% year-on-year

Free CashFlow

Annual FCF

-$288.40 M
EQRXW annual free cash flow is -$288.40 million

Annual FCF 1-Year Change

-57.06%
EQRXW annual free cash flow is down -57.06% year-on-year

CAPEX

Annual CAPEX

$1.13 M
EQRXW annual capital expenditures is $1.13 million

Annual CAPEX 1-Year Change

+152.9%
EQRXW annual capital expenditures is up +152.9% year-on-year

Institutional Ownership

Similar stocks

FAQ

  • What is the ticker symbol for EQRx?
  • Does EQRx pay dividends?
  • What sector is EQRx in?
  • What industry is EQRx in?
  • What country is EQRx based in?
  • When did EQRx go public?
  • Is EQRx in the S&P 500?
  • Is EQRx in the NASDAQ 100?
  • Is EQRx in the Dow Jones?
  • When does EQRx report earnings?

What is the ticker symbol for EQRx?

The ticker symbol for EQRx is NASDAQ:EQRXW

Does EQRx pay dividends?

No, EQRx does not pay dividends

What sector is EQRx in?

EQRx is in the Healthcare sector

What industry is EQRx in?

EQRx is in the Biotechnology industry

What country is EQRx based in?

EQRx is headquartered in United States

When did EQRx go public?

EQRx's initial public offering (IPO) was on December 20, 2021

Is EQRx in the S&P 500?

No, EQRx is not included in the S&P 500 index

Is EQRx in the NASDAQ 100?

No, EQRx is not included in the NASDAQ 100 index

Is EQRx in the Dow Jones?

No, EQRx is not included in the Dow Jones index

When does EQRx report earnings?

The date for EQRx's next earnings report has not been announced yet